1 / 23

Genetics and Pathology

Genetics and Pathology. What can they do for each other?. Scottish Association of Histotechnology; Friday 27 th May 2011. National Initiatives Affecting Both Disciplines. Scottish Genetic Laboratory Consortium. Nationally funded NHS Genetic Services

ahava
Télécharger la présentation

Genetics and Pathology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Genetics and Pathology What can they do for each other? Scottish Association of Histotechnology; Friday 27th May 2011

  2. National Initiatives Affecting Both Disciplines

  3. Scottish Genetic Laboratory Consortium • Nationally funded NHS Genetic Services • Four centre Consortium covering service Genetics for Scotland • Responsible for a wide range of inherited genetic conditions

  4. Genetics and Pathology in NHS Tayside • Future workload of Genetics will increasingly be Molecular Pathology/Diagnostic tests • Changes at the chromosome and DNA level will • Aid diagnosis • Determine outcome • Define treatment pathways • Partnership with Pathology is crucial for effective delivery of Molecular Diagnostic tests • Excellent relationship between Pathology and Genetics in Tayside

  5. Pathology Sample

  6. The starting point for all Molecular tests is DNA 2x10mm • Yield is 1.1mg (20ml at 55ng/ml)

  7. A good example of how Genetics and Pathology can work together for inherited cancer is Lynch syndrome • Familial colorectal cancer syndrome characterised by hundreds of colorectal polyps as well as extra-colonic tumours • Important to distinguish families at high risk of Lynch syndrome from sporadic disease • Done through combination of genetic techniques and IHC on tumour sections. • Allows targeted testing of tumours for MMR defects

  8. “Best approach for identifying cases of Lynch syndrome is for Pathologists and Geneticists to work closely together” • “MSI and IHC were most cost effective when used as an initial screening strategy”

  9. Diagnostic testing – HNPCC and MSI Medium Risk MSI + IHC

  10. BAT-25 NR-21 NR-24 BAT-26 MONO-27 MSI+ / MHLH neg

  11. Diagnostic testing – HNPCC and MSI

  12. Genetics and Sporadic Cancer “Not all cancer is inherited but all cancer is genetic” IgH & TCR gene rearrangements Diagnostic MSI BRAF p.V600E KRAS Prognostic cKIT / PDGFR Her2

  13. Prognostic testing – KRAS and cKIT/PDGFRA • The presence of a mutation in KRAS in colorectal cancer or a cKIT / PDGFRA mutation in GIST can have significant implications for treatment. • KRAS • Approximately 30-50% of colorectal tumours have a mutation at 3 codons in gene • Tumours with a mutation will not respond to a specific class of treatment • Important for patients to know what the mutation status of their tumour is • GIST • 85-90% of GISTs have activating mutations in cKIT or PDGFRA • The position of the mutation can influence how the tumour will respond to specific treatment.

  14. KRAS

  15. For KRAS testing crucial to get good quality tissue sections and to know the tumour load

  16. GIST

  17. What can be gained by working together? • Shared expertise, skills and capital equipment • Opportunities for integrated training at various career levels • Opportunity to develop specialist teams • Shared R&D • Collaborative working is only way of delivering Molecular Pathology/Diagnostics • Future proof both disciplines • Ultimately provide the best service to patients.

  18. New initiatives in Scotland • Training in Molecular Pathology/Diagnostics funded by NES • Molecular Pathology Consortium

  19. The Future for Genetics and Pathology

  20. THANKS Everyone in Pathology at Ninewells Hospital

More Related